 |
|
|
 |
|
Drug-Coated Stents Don't Boost Death Risk, U.S. Advisers Say
|
 |  |  |  | Related Healthscout Videos |  |
|
Page: << Prev | 1 | 2 | 3 | 4 Schulman, who co-authored the JAMA report, said the Duke researchers found that patients who get drug-eluting stents need to stay on blood thinners much longer than currently indicated.
"Our analysis says if you don't use stents correctly, you could be hurting patients," he said. "What kind of medication people need to be on long term is a very major concern."
More information
Text Continues Below

For more on stents, visit the American Heart Association (www.americanheart.org ).
Page: << Prev | 1 | 2 | 3 | 4
|
Copyright © 2006 ScoutNews, LLC. All rights reserved.
Last updated 12/8/2006
|
 |

SOURCES: Robert Michler, M.D., chairman, department of cardio-thoracic surgery, and director, heart center, Montefiore Medical Center/Albert Einstein College of Medicine, New York City; Kevin Schulman, M.D., professor, medicine, Duke University School of Medicine, Durham, N.C.; Michael Attubato, M.D., associate director, invasive and interventional cardiology, New York University Medical Center, New York City; Associated Press; Washington Post; Dec. 5, 2006, Journal of the American College of Cardiology; Dec. 6, 2006, Journal of the American Medical Association
|